相关实验视频

Updated: Jul 16, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

在肝细胞癌的突变景观和精准医学

Leva Gorji¹, Zachary J Brown², Timothy M Pawlik³

¹Department of Surgery, Kettering Health Dayton, Dayton, OH 45405, USA.

|September 9, 2023

概括

肝细胞癌 (HCC) 管理正在通过精准医学得到改善. 基因分析和生物标志物为这种常见癌症提供了个性化治疗,以获得更好的结果.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

肝细胞癌 (HCC) 是一种全球普遍存在的恶性瘤,发病率不断上升,预后不佳.
目前对HCC的治疗方法,包括切除和移植,都有局限性,往往导致高复发率和死亡率.
了解瘤微环境和突变格局对于推进HCC控制至关重要.

研究的目的:

审查肝细胞癌 (HCC) 的分子标.
讨论精准医学在管理HCC中的当前作用和未来潜力.
突出生物标志物对于诊断,治疗选择和监测的重要性.

主要方法:

文献综述侧重于HCC中的分子标和精密医学.
对下一代测序数据进行分析,以识别瘤突变.
对各种临床应用的HCC生物标志物的研究.

主要成果:

使用基因分析和下一代测序的精准医学正在增强针对HCC的向治疗方法.
生物标志物研究正在推动诊断准确性,治疗反应预测和疾病监测.
识别分子标和了解突变格局是个性化HCC管理的关键.

结论:

精准医学为个性化HCC治疗策略提供了一个有前途的途径.
分子分析和生物标志物发现对于改善患者的治疗结果和克服治疗挑战至关重要.
对HCC的分子基础的持续研究对于开发新的治疗机会至关重要.

关键词:

肝细胞癌是肝细胞癌.精准医学是一门精准医学.有针对性的治疗.

更多相关视频

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...